top of page
Search


Agentic AI in healthcare in 2025: Separating the near-term use cases from the hype
Agentic AI in healthcare has rapidly become the centerpiece of health tech discussions. We’ve been studying it because it’s an area of rapid growth and advancement—an outlier in this moment in healthcare, when stakeholders across the industry are struggling amidst rising expenses, workforce shortages, and patient experience frustrations. Agentic AI tools are being positioned as a game-changing approach to addressing many of the industry’s biggest challenges, given their state

Marina Renton
Nov 78 min read


Different players, different games: How healthcare’s various sectors are using AI differently in 2025
All U.S. health systems, hospitals, provider groups, life sciences organizations, and national or regional payers are racing to scale AI....

Chris Loumeau
Sep 129 min read


Hospital revenue cycle trends to watch in 2025-2026: Key takeaways from our Provider RCM Summit
Last week, Union Healthcare Insight had the privilege of gathering with an impressive group of hospital revenue cycle executives in...

Eric Fontana
Aug 146 min read


AI scribes: The promise, the uptake pattern–and some pitfalls in the mix
AI scribes for clinicians are clearly a compelling idea—but to what extent are adoption and results matching up? It can be hard to tell,...

Chris Loumeau
Jul 318 min read


What's going on with Payer A.I., denials and audits?
In the last couple of months, we’ve been pulling up chairs with dozens of revenue cycle leaders to understand what’s keeping them awake...

Eric Fontana
Jul 2311 min read


Synthetic clinical data reality check - not so fast, data replacers
Quick rewind: our tour of the clinical data market that ended in a cliffhanger In Part 1 of this blog post (linked below if you missed...

Amanda Berra
Jun 279 min read


Welcome to the clinical data market
Health system leaders have long been interested in figuring out ways to monetize clinical data. It makes sense: if they could sell or license de-identified data in their EHRs to life science or tech companies, that would be very helpful from a revenue diversification perspective. Especially whenever core inpatient economics are under siege. But, it’s always been an easier-said-than-done proposition. And now, maybe there's also a new spoiler in the mix, in the form of 'synthe

Amanda Berra
May 2210 min read


Four points about the strategic significance of Epic in healthcare
Four basic points that every healthcare executive should be familiar with about Epic in healthcare

Amanda Berra
Jan 3011 min read


Theory versus reality in the state of healthcare disruption
Healthcare disruption has been a hot (and noisy) topic in recent years. For the last decade, the healthcare industry has been rich in...

Amanda Berra
Jun 7, 20245 min read


How to judge a good AI investment
You've probably noticed that we—not unlike literally everyone else—have been covering artificial intelligence quite a bit lately. We've...

Christopher Kerns
Apr 10, 20242 min read


Get your execs up to speed on AI
Check out our excerpt from our healthcare strategy bootcamp on healthcare AI in the link above—and if you'd like complimentary access to...

Christopher Kerns
Apr 4, 20242 min read


Doubling down on what I said
In Union's recent Board Briefing on where the smart money is going in 2024 (members can access the on-demand webinar here), I made a bit...

Christopher Kerns
Mar 6, 20242 min read
Join our mailing list
Get access to our latest posts
bottom of page
